
NNVC
Healthcare · Biotechnology · $31.4M market cap
$1.23-0.12 (-8.9%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +10.0% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2026 | Time not confirmed | -0.10 | — | — |
| Sep 28, 2026 | After the close | -0.11 | -0.10 | +9.1% |
| May 15, 2026 | Before the open | -0.08 | -0.09 | -12.5% |
| Feb 17, 2026 | After the close | -0.08 | -0.11 | -37.5% |
| Nov 14, 2025 | After the close | -0.18 | -0.10 | +44.4% |
| Sep 3, 2025 | Time not confirmed | -0.20 | -0.12 | +40.0% |
| May 15, 2025 | Time not confirmed | -0.19 | -0.14 | +26.3% |
| Feb 12, 2025 | After the close | -0.18 | -0.14 | +22.7% |
| Nov 12, 2024 | After the close | -0.17 | -0.23 | -34.1% |
| Sep 27, 2024 | After the close | -0.20 | -0.19 | +5.0% |
| May 15, 2024 | After the close | -0.19 | -0.16 | +15.8% |
| Feb 14, 2024 | After the close | -0.19 | -0.18 | +5.3% |
| Nov 14, 2023 | After the close | -0.17 | -0.17 |
NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability; NV-387 as an active ingredient of drug product formulations for the…
| 0.0% |
| Aug 30, 2023 | Time not confirmed | -0.17 | -0.31 | -79.5% |
| May 15, 2023 | After the close | -0.17 | -0.15 | +11.8% |
| Feb 14, 2023 | After the close | -0.16 | -0.15 | +6.3% |
| Nov 14, 2022 | After the close | -0.17 | -0.14 | +17.6% |
| Aug 31, 2022 | Time not confirmed | -0.15 | -0.15 | 0.0% |
| May 16, 2022 | After the close | -0.22 | -0.16 | +27.3% |
| Feb 14, 2022 | After the close | -0.22 | -0.17 | +22.7% |
| Nov 15, 2021 | After the close | -0.20 | -0.23 | -15.0% |
| Sep 1, 2021 | Time not confirmed | — | -0.18 | — |
| May 14, 2021 | After the close | — | -0.19 | — |
| Feb 16, 2021 | After the close | — | -0.22 | — |
| Nov 16, 2020 | After the close | — | -0.22 | — |
| Sep 2, 2020 | Time not confirmed | — | -0.23 | — |
| Jun 22, 2020 | After the close | — | -1.24 | — |
| Feb 14, 2020 | After the close | -0.60 | -0.50 | +16.7% |
| Nov 15, 2019 | After the close | — | -0.41 | — |
| Aug 23, 2019 | After the close | -0.80 | -0.60 | +25.0% |
| May 15, 2019 | After the close | -0.60 | -0.60 | 0.0% |
| Feb 14, 2019 | After the close | -0.60 | -0.60 | 0.0% |
| Oct 12, 2018 | After the close | — | -0.60 | — |
| Aug 29, 2018 | Time not confirmed | — | -0.02 | — |
| May 21, 2018 | After the close | — | -0.03 | — |
| Feb 20, 2018 | After the close | — | -0.04 | — |